OncoSec Reports Positive Results from Phase II Trial of ImmunoPulse IL-12 in MCC
September 27, 2015 at 12:59 PM EDT
OncoSec Medical Incorporated (NASDAQ: ONCS) today announced results from a Phase II trial demonstrating that its investigational ...